Trial intelligence / Profile preview

Aminophylline for renal function after liver transplantation

IRCT20141009019470N79Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of aminophylline in chronic kidney disease (CKD) and nephropathy, sponsored by Shiraz University of Medical Sciences. Started May 2019; status: completed.

02

Drugs

aminophylline
03

Conditions

chronic kidney disease (CKD)nephropathy

Beyond the preview

Go deeper on IRCT20141009019470N79.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141009019470N79.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call